Abstract
Clinicians have always personalised patient management. There is a growing momentum to improve this further through the integration of genomic information into clinical care. This will incorporate powerful new tools, through which clinicians can further tailor healthcare, improving disease prevention, prediction, diagnosis and treatment. This article aims to suggest ways in which this revolution in healthcare will affect GPs.
Get full access to this article
View all access options for this article.
References
1.Department of Health. (2014). Statins benefit and risks drug safety update. Retrieved from www.gov.uk/drug-safety-update/statins-benefits-and-risks .
2.Health Education England. Genomics education programme. Retrieved from www.genomicseducation.hee.nhs.uk .
3.RCGP. Clinical module 3.02: Genetics in primary care. Retrieved from www.rcgp.org.uk/training-exams/gp-curriculum-overview/online-curriculum/applying-clinical-knowledge-section-1/3-02-genetics-in-primary-care.aspx .
4.RCGP. Genetics in cancer. Retrieved from www.rcgp.org.uk/learning/online-learning/ole/genetics-in-cancer.aspx .
5.St George’s, University of London. The genomics era: The future of genetics in medicine. Retrieved from www.futurelearn.com/courses/the-genomics-era .
6.UK Genetic Testing Network. http://ukgtn.nhs.uk/ .
7.UK Pharmacogenetics and Stratified Medicine Network. www.uk-pgx-stratmed.co.uk .
8.
Wilke
R. A.
Ramsey
L. B.
Johnson
S. G.
Maxwell
W. D.
McLeod
H. L.
Voora
D.
Niemi
M.
(2012 ) The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin- induced myopathy . Clinical Pharmacology and Therapeutics 92 (1 ): 112 –117 . doi: 10.1038/clpt.2012.57 .